Canada Poised to Publish Proposal on Confidential Business Disclosure
Government agency Health Canada has announced plans to back industry-supported changes on disclosure of ingredient concentrations before fully implementing the updated Workplace Hazardous Materials Information System (WHMIS 2015).
However, it will wait until after the the changes kick in before addressing labour organisations' demands. Labour organisations had wanted the government to consider them during the implementation delay announced in June.
Health Canada had already delayed its deadline for new manufacturer and importer safety data sheets (SDS) and labels to 1 June 2018 and the deadline for distributors to 1 September. It has left the employer deadline at 1 December.
Speaking at the Society for Chemical Hazard Communication (SCHC) conference in Arlington, Va., Rosslynn Miller-Lee, Director of Health Canada's Workplace Hazardous Materials Bureau, made it clear that the agency did not plan on letting the deadlines shift further. "This miracle will not happen again," she said
The agency plans to propose an amendment to the Hazardous Products Regulations (HPR) that would allow manufacturers to report a broad range, instead of a specific concentration, of an ingredient if the concentration can be defended as confidential business information (CBI), Ms Miller-Lee said. The proposed schedule of concentration ranges will be published for public comment.
A review process for CBI claims
The Hazardous Materials Information Review Act (HMIRA) sets out a review process for CBI claims. But because the previous labelling rules allowed manufacturers to avoid specifying chemical concentrations, they used that flexibility to protect the information, avoiding the application process and associated fee, Ms Miller-Lee said.
With the new rules on the horizon, CBI claims went from 423 in 2015-16 to 1,312 in 2016-17. Another 707 have been submitted since April. However, submissions essentially ceased after the delay was announced in June.
Ms Miller-Lee said the pending change will not allow manufacturers to continue avoiding the CBI process. "In order to protect concentration ranges you must use the CBI protection mechanism. This discussion is about concentration, not identity".
Labour concerns
Ms Miller-Lee said the agency will wait until after implementation to address labour group demands that manufacturers should not be allowed to avoid disclosing the presence of carginogens, mutagens, reproductive toxicants and respiratory sensitisers. They also want the labelling rules to apply to some consumer products.
The first change would require a legislative amendment to HMIRA. Applying labelling to consumer products would require a regulatory amendment.
"The concern is that workers could be exposed to consumer products in a different way and SDS are not provided," Ms Miller-Lee said.
"We are at the beginning of this conversation, so I can't say much. What I can say for sure is that no changes will be made to the regulations until we complete the transition period," she said. "We want to be sure everyone knows how to comply with the regulations as they are before we start changing them."
2026-09-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
PPG launches strategic review: intends to sell North American architectural coatings business with annual revenue of nearly US$1.8 billion
-
Canada's frozen snow crab export trade has performed poorly this year
-
Danning tablets have been successfully exported to Canada and entered the international mainstream drug market
-
Canada sets MRLs for pesticides such as Tiafenacil in some foods
-
NexusBioAg and MustGrow Biologics Announce Exclusive Marketing and Distribution Agreement in Canada
-
Enable the Use of Polysorbate 80 as an Emulsifying Agent
-
Canadian approved industrial grade ethanol for hand sanitizer
-
Rapeseed planting industry suffered unprecedented impact
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
Recommend Reading
-
Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
GM Crop Area Reaches 216 Million Hectares
-
China’s Acetone Market in 2025 Continues to Decline, Constantly Reaching New Lows
-
Business Society’s Market Outlook for Natural Rubber on August 25, 2026: Strong Consolidation with a Slight Bullish Bias
-
Negative Factors Pressurize, Hydrogen Peroxide Market Prices Weakly Decline in January
-
Will 2026 Bring a Turnaround After DMF Prices Hit Bottom in 2025 in China?
-
Business Society’s LDPE Market Outlook on August 25, 2026: Volatile